| A prospective study of 18F-DCFPyL PSMA PET/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy W Liu, K Zukotynski, L Emmett, HT Chung, P Chung, R Wolfson, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 546-555, 2020 | 49 | 2020 |
| Stereotactic radiation for lung cancer: a practical approach to challenging scenarios N Andruska, HB Stowe, C Crockett, W Liu, D Palma, C Faivre-Finn, ... Journal of Thoracic Oncology 16 (7), 1075-1085, 2021 | 21 | 2021 |
| Oligometastases: emerging evidence W Liu, H Bahig, DA Palma Journal of Clinical Oncology 40 (36), 4250-4260, 2022 | 17 | 2022 |
| Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based? MT Corkum, W Liu, DA Palma, GS Bauman, RE Dinniwell, A Warner, ... Radiation Oncology 13, 1-8, 2018 | 14 | 2018 |
| Utilization of salvage and systemic therapies for recurrent prostate cancer as a result of 18F-DCFPyL PET/CT restaging W Liu, K Zukotynski, L Emmett, HT Chung, P Chung, R Wolfson, ... Advances in Radiation Oncology 6 (1), 100553, 2021 | 11 | 2021 |
| Histologic validation of auto-contoured dominant intraprostatic lesions on [18F] DCFPyL PSMA-PET imaging R Alfano, GS Bauman, W Liu, JD Thiessen, I Rachinsky, W Pavlosky, ... Radiotherapy and Oncology 152, 34-41, 2020 | 11 | 2020 |
| What is the optimal radiotherapy utilization rate for lung cancer?—a systematic review W Liu, A Liu, J Chan, RG Boldt, P Munoz-Schuffenegger, AV Louie Translational lung cancer research 8 (Suppl 2), S163, 2019 | 11 | 2019 |
| Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician’s guide S Young, W Liu, K Zukotynski, G Bauman Expert Review of Anticancer Therapy 21 (6), 641-655, 2021 | 10 | 2021 |
| Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI W Liu, H Fakir, G Randhawa, R Alfano, M Corkum, Z Kassam, I Rachinsky, ... Clinical and Translational Radiation Oncology 32, 41-47, 2022 | 8 | 2022 |
| Imaging biomarkers in prostate stereotactic body radiotherapy: A review and clinical trial protocol W Liu, A Loblaw, D Laidley, H Fakir, L Mendez, M Davidson, Z Kassam, ... Frontiers in Oncology 12, 863848, 2022 | 5 | 2022 |
| Preliminary results of a prospective, multicenter trial assessing the impact of 18F-DCFPyL-PET/CT on the management of patients with recurrent prostate cancer. U Metser, K Zukotynski, W Liu, D Langer, P MacCrostie, LKJ Chin, ... Journal of Nuclear Medicine 61 (supplement 1), 40-40, 2020 | 3 | 2020 |
| Case–Prostate-specific antigen bounce: A pitfall in prostate-specific membrane antigen positron emission tomography/computed tomography interpretation VP Pedro, G Sistani, I Rachinsky, K Zukotynski, G Bauman, W Liu Canadian Urological Association Journal 15 (11), E620, 2021 | 2 | 2021 |
| Incidence and risk factors for euthanasia or physician-assisted suicide in oncology patients: A systematic review. W Liu, L Liu, A Liu, S Jia, T Liu, G Boldt, M Qu, I Ball Journal of Clinical Oncology 39 (15_suppl), 12034-12034, 2021 | 1 | 2021 |
| Prostate SBRT–Using 18F PSMA-1007 PET and Multiparametric MRI to escalate the dose to Dominant Intraprostatic Lesions (DILs)–ARGOS CLIMBER trial A Dhar, H Fakir, A Loblaw, D Laidley, W Liu, LC Mendez, Z Kassam, ... Cureus Journal of Medical Science, 2023 | | 2023 |
| 240 Using 18F PSMA-1007 PET and Multiparametric MRI with Prostate SBRT to Escalate the Dose to Dominant Intraprostatic Lesions-ARGOS-Climber: Interim Results of a Phase I/II … A Dhar, G Bauman, L Mendez, H Fakir, D Laidley, Z Kassam, W Liu, ... Radiotherapy and Oncology 186, S103-S104, 2023 | | 2023 |
| Medical Assistance in Dying in Oncology Patients: A Canadian Academic Hospital’s Experience T Liu, W Liu, A Leung, S Jia, P Lee, L Liu, A Mutsaers, S Miller, ... Current Oncology 29 (12), 9407-9415, 2022 | | 2022 |
| PSMA PET-and mpMRI-directed Prostate Cancer Salvage W Liu, G Bauman International Journal of Radiation Oncology, Biology, Physics 114 (5), 1053-1054, 2022 | | 2022 |
| Medical Assistance in Dying in Oncology Patients: A Canadian Academic Hospital Experience W Liu, T Liu, A Leung, L Liu, S Miller, K Honarmand, M Qu, I Ball International Journal of Radiation Oncology, Biology, Physics 111 (3), e488, 2021 | | 2021 |
| 113: Re-Evaluating the Toxicity of Radiotherapy in Patients with Collagen Vascular Disease: A Meta-Analysis of Propensity Score Studies W Liu, B Liu, A Leung, J Park, G Boldt, D Palma, M Lock Radiotherapy and Oncology 163, S49, 2021 | | 2021 |
| Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective … W Liu, K Zukotynski, G Bauman European Urology 80 (3), e77-e78, 2021 | | 2021 |
Glenn BaumanProfessor, Department of Oncology, Western UniversityVerified email at lhsc.on.ca
